Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: An interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynakologische Onkologie ovarian cancer study group

Seminars in Oncology

Volumn 24, Issue 5 SUPPL. 15, 1997, Pages

  Du Bois, A ^a   Luck, H J ^a   Meier, W ^a   Mobus, V ^a   Costa, S ^a   Richter, B ^a   Warm, M ^a   Bauknecht, T ^a   Schroder, W ^a   Olbricht, S ^a   Nitz, U ^a   Jackisch, C ^a  

^a St Vincentius Krankenhauser ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL; TAXANE DERIVATIVE;

ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUTROPENIA; OVARY CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; ARTHRALGIA; CARBOPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GERMANY; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM, RESIDUAL; NEUTROPENIA; OVARIAN NEOPLASMS; PACLITAXEL; PAIN; PATIENT SELECTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; QUALITY OF LIFE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

EID: 0030824319     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)